specialty medications

Top considerations when determining whether to approve expensive drugsWeighing the ethics of approving expensive cancer drugs for patients facing terminal disease is a multifaceted endeavor. Here are some recommendations.
Creating a ‘robust’ specialty pharmacy networkThe correct approach to take when creating a specialty pharmacy network is a key issue for healthcare executives.
ACA reform must preserve mental health pharmacy accessACA repeal or replacement must focus on how to preserve mental health services and pharmacy access.
The year's Top Drugs
The year's Top DrugsSpecialty medications dominate
Are your prior auth provisions stifling medication adherence?Prior authorizations are here to stay. Are yours working against you? Find out.
Employers aim to curb specialty drug costsA new survey reveals what employers' medical plans are doing to rein in specialty drug cost and utilization.
Five ways to contain the specialty drug spendThe high cost of specialty medications requires an array of management techniques, according to a recent presentation at the Academy of Managed Care Pharmacy Nexus 2015. Read more.
Specialty drugs in the pipeline: 4 heavily impacted diseasesA senior clinical consultant at Express Scripts says it's critical for healthcare executives to keep an eye on how specialty medications in the pipeline will impact these four conditions.
Specialty medications and managed care: The impact and forecastHow will the increasing number of approvals for specialty medications affect managed care? Aimee Tharaldson, of Express Scripts, weighs in.
Game-changing meds deliver new hope for Hep C patientsThe new-gen treatments for Hep C can make the illness go away, but their extreme price tags make insurance co-pays unaffordable, and many patients just stay sick.